Overview

Inositol Supplementation to Treat PCOS (INSUPP-PCOS)

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
To determine if Inositol, a dietary supplement, will improve ovarian and adrenal androgen excess in women with Polycystic Ovarian Syndrome(PCOS).
Phase:
Phase 2
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)
Treatments:
Inositol